BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7360142)

  • 1. The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
    Rogers AM; Hill R; Lehmann AR; Arlett CF; Burns VW
    Mutat Res; 1980 Jan; 69(1):139-48. PubMed ID: 7360142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for indirect involvement of thymidine kinase in excision repair processes in mouse cell lines.
    McKenna PG; Yasseen AA; McKelvey VJ
    Somat Cell Mol Genet; 1985 May; 11(3):239-46. PubMed ID: 3859020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl methanesulphonate mutagenesis in L5178Y mouse lymphoma cells.
    Cole J; Arlett CF
    Mutat Res; 1978 Apr; 50(1):111-20. PubMed ID: 205781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative mutagenicity of 4 DNA-intercalating agents in L5178Y mouse lymphoma cells.
    Rogers AM; Back KC
    Mutat Res; 1982 Dec; 102(4):447-55. PubMed ID: 7177152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell.
    Amacher DE; Turner GN
    Mutat Res; 1987 Jan; 176(1):123-31. PubMed ID: 2432424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction of mutants in L5178Y mouse lymphoma cells by 4-chloromethylbiphenyl.
    Arlett CF; Muriel WJ; Cole J; Lowe J
    Mutat Res; 1982; 100(1-4):253-6. PubMed ID: 7057756
    [No Abstract]   [Full Text] [Related]  

  • 8. The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/- (3.7.2c)] mouse lymphoma cells.
    Cole J; Muriel WJ; Bridges BA
    Mutagenesis; 1986 Mar; 1(2):157-67. PubMed ID: 3333272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl methanesulphonate mutagenesis with L5178Y mouse lymphoma cells: a comparison of ouabain, thioguanine and excess thymidine resistance.
    Cole J; Arlett CF
    Mutat Res; 1976 Mar; 34(3):507-25. PubMed ID: 1264112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
    Clive D; Glover P; Applegate M; Hozier J
    Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control cultures.
    Blazak WF; Los FJ; Rudd CJ; Caspary WJ
    Mutat Res; 1989 Oct; 224(2):197-208. PubMed ID: 2507912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutagenic potency of 1,8-dinitropyrene in cultured mouse lymphoma cells.
    Cole J; Arlett CF; Lowe J; Bridges BA
    Mutat Res; 1982 Mar; 93(1):213-20. PubMed ID: 6801506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of ouabain-resistant mutants of the mouse lymphoma cell line L5178Y.
    Muriel WJ; Cole J; Lehmann AR
    Mutagenesis; 1987 Sep; 2(5):383-9. PubMed ID: 2830454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on three mutagen-sensitive mutants of mouse L5178Y cells. I. Characterization of the hybrids between L5178Y and mutagen-sensitive mutants.
    Shiomi T; Hieda-Shiomi N; Sato K
    Mutat Res; 1982 Aug; 95(2-3):313-25. PubMed ID: 6811889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
    Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour promoter TPA does not affect mutation to ouabain resistance in L5178Y mouse lymphoma cells.
    Lasne C; Cole J; Arlett CF
    Carcinogenesis; 1980 Jul; 1(7):627-31. PubMed ID: 11219839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dosimetry of the chemical mutagen ethyl methanesulfonate: quantitative comparison of mutation induction in Escherichia coli, V79 Chinese hamster cells and L5178Y mouse lymphoma cells, and some cytological results in vitro and in vivo.
    Aaron CS; van Zeeland AA; Mohn GR; Natarajan AT; Knaap AG; Tates AD; Glickman BW
    Mutat Res; 1980 Feb; 69(2):201-16. PubMed ID: 6987499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
    Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
    Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.